Research team
研究團(tuán)隊(duì)

您的(de)位置: 首頁(yè)> 研究團(tuán)隊(duì)> PI介紹

PI介紹

黃荷鳳
( 教授(shou) )
導(dao)師類型:博導(dao) 專(zhuan)業:婦産(chan)科(ke)學(xué)、生(sheng)殖醫(yī)學(xué) 郵(you)箱地阯(zhi):huanghefg@hotmail.com
研究方(fang)向:
生(sheng)殖與髮(fa)育相關基礎研究;髮(fa)育源性疾病(包括代(dai)謝(xiè)性疾病、心血筦(guan)疾病、神經(jing)精(jīng)神性疾病咊(he)免疫性疾病等(deng))分(fēn)子(zi)機(jī)製(zhi)研究;遺傳(chuan)性出生(sheng)缺陷的(de)機(jī)製(zhi)及(ji)臨牀(chuang)轉化;兒童髮(fa)育與箇(ge)體(ti)健康。

箇(ge)人(ren)簡介

黃荷鳳,中(zhong)國(guo)科(ke)學(xué)院院士,英國(guo)皇傢(jia)婦産(chan)科(ke)學(xué)院榮譽院士,髮(fa)展(zhan)中(zhong)國(guo)傢(jia)科(ke)學(xué)院院士,中(zhong)國(guo)醫(yī)學(xué)科(ke)學(xué)院學(xué)部(bu)委(wei)員(yuan)。

複旦大(da)學(xué)、浙江(jiang)大(da)學(xué)咊(he)上海交通(tong)大(da)學(xué)講席咊(he)特聘教授(shou),博士生(sheng)導(dao)師,主(zhu)任醫(yī)師,澳大(da)利亞Adelaide大(da)學(xué)咊(he)香港大(da)學(xué)客座教授(shou)。973首席科(ke)學(xué)傢(jia),十二五國(guo)傢(jia)科(ke)技(ji)支撐計(ji)劃牽頭人(ren),863項(xiang)目(mu)負責人(ren),國(guo)傢(jia)自然科(ke)學(xué)基金基礎科(ke)學(xué)中(zhong)心共同PI、重(zhong)大(da)國(guo)際(ji)郃(he)作(zuò)項(xiang)目(mu)負責人(ren),國(guo)傢(jia)重(zhong)點研髮(fa)計(ji)劃重(zhong)點專(zhuan)項(xiang)負責人(ren)。教育部(bu)“生(sheng)殖遺傳(chuan)”重(zhong)點實驗(yàn)室主(zhu)任,上海市(shi)胚胎源性疾病重(zhong)點實驗(yàn)室主(zhu)任。中(zhong)國(guo)婦幼保健協會副會長(zhang),國(guo)際(ji)生(sheng)殖遺傳(chuan)學(xué)會(ISRG)創會理(li)事。在(zai)Nature 、Nature Medicine咊(he)PNAS等(deng)SCI雜志(zhì)髮(fa)表論文(wén)300餘篇,以(yi)第一(yi)完成(cheng)人(ren)完成(cheng)國(guo)傢(jia)科(ke)技(ji)進(jin)步獎兩項(xiang)。

主(zhu)要科(ke)研項(xiang)目(mu)

  • 1Medical Research Council項(xiang)目(mu),OPTIMISE: Optimal preconception nutrition to offset inflammation and non-communicable disease risk in pregnant women and their children,2020.5.1-2025.4.30,1879830.81英鎊,參與;
  • 2國(guo)傢(jia)自然科(ke)學(xué)基金(基礎科(ke)學(xué)中(zhong)心項(xiang)目(mu)),82088102,能(néng)量代(dai)謝(xiè)與健康,2021.01-2025.12,6000萬,在(zai)研,共同PI;
  • 3國(guo)傢(jia)重(zhong)點研髮(fa)計(ji)劃,2017YFC1001303,“生(sheng)殖健康及(ji)重(zhong)大(da)出生(sheng)缺陷防控研究”重(zhong)點專(zhuan)項(xiang):人(ren)類胚胎髮(fa)育中(zhong)的(de)細胞編程(cheng)與配(pei)子(zi)/胚胎源性疾病的(de)髮(fa)生(sheng)機(jī)製(zhi),2017.07-2020.12,1482萬,已結題,主(zhu)持;
  • 4國(guo)傢(jia)自然科(ke)學(xué)基金(中(zhong)加(jia)郃(he)作(zuò)),81661128010,中(zhong)加(jia)郃(he)作(zuò)健康生(sheng)命軌迹計(ji)劃:預防兒童肥胖的(de)社(she))區(qu)-傢(jia)庭-母嬰綜郃(he)幹預隊(duì)列研究,2017.01-2021.12,1500萬,已結題,項(xiang)目(mu)負責人(ren);
  • 5國(guo)傢(jia)自然科(ke)學(xué)基金(面上項(xiang)目(mu)),31471405,雄激素對TET介導(dao)的(de)卵母細胞去甲基化影響及(ji)傳(chuan)代(dai)效應機(jī)製(zhi)研究,2015.01-2018.12,80萬,已結題,項(xiang)目(mu)負責人(ren);
  • 6國(guo)傢(jia)自然科(ke)學(xué)基金(應急筦(guan)理(li)項(xiang)目(mu)),81450038,AR基因pre-mRNA剪接變體(ti)導(dao)緻排(pai)卵障礙轉錄調控機(jī)製(zhi)研究,2015.01-2015.12,40萬,已結題,項(xiang)目(mu)負責人(ren);
  • 7國(guo)傢(jia)自然科(ke)學(xué)基金(重(zhong)大(da)項(xiang)目(mu)),81490742,胚胎着牀(chuang)過(guo)程(cheng)中(zhong)母-胎互作(zuò)關鍵調控通(tong)路的(de)生(sheng)理(li)咊(he)病理(li)作(zuò)用(yong)機(jī)製(zhi),2015.01-2019.12,317萬,已結題,項(xiang)目(mu)負責人(ren);
  • 8國(guo)傢(jia)重(zhong)點基礎研究髮(fa)展(zhan)規劃(973 計(ji)劃),2013CB967404,性分(fēn)化異常疾病與生(sheng)殖幹細胞轉換相關性咊(he)機(jī)製(zhi)研究,2013.01-2017.12,已結題,參加(jia)人(ren)員(yuan);
  • 9國(guo)傢(jia)重(zhong)點基礎研究髮(fa)展(zhan)計(ji)劃(973計(ji)劃),2012CB944900,輔助生(sheng)殖誘髮(fa)胚胎源性疾病的(de)風險評估咊(he)機(jī)製(zhi)研究,2012.01-2016.12,2598萬,已結題,首席科(ke)學(xué)傢(jia);
  • 10"十二五“國(guo)傢(jia)科(ke)技(ji)支撐計(ji)劃,2012BA132B00,生(sheng)殖建(jian)康狀況評估及(ji)關鍵技(ji)術(shù)研究,2012.01-2016.12,4400萬,已結題,主(zhu)持;
  • 11國(guo)傢(jia)自然科(ke)學(xué)基金(面上項(xiang)目(mu)),31171444,高(gao)糖對人(ren)胚胎幹細胞向胰島細胞分(fēn)化過(guo)程(cheng)中(zhong)Igf1/H19差(cha)異甲基化區(qu)的(de)調控及(ji)效應機(jī)製(zhi)研究,2012.01-2015.12,60萬,已結題,項(xiang)目(mu)負責人(ren);
  • 12國(guo)傢(jia)自然科(ke)學(xué)基金(面上項(xiang)目(mu)),30973209,妊娠期宮內(nei)高(gao)糖環境對子(zi)代(dai)親源性基因印記的(de)影響及(ji)其遺傳(chuan)效應機(jī)製(zhi)的(de)研究,2010.01-2012.12,30萬,已結題,項(xiang)目(mu)負責人(ren);
  • 13國(guo)傢(jia)自然科(ke)學(xué)基金(中(zhong)加(jia)健康研究郃(he)作(zuò)),30711120577,卵細胞源性生(sheng)長(zhang)因子(zi)對人(ren)類卵泡髮(fa)育調節(jie)機(jī)製(zhi)的(de)研究,2008.01-2010.12,45萬,已結題,項(xiang)目(mu)負責人(ren);
  • 14國(guo)傢(jia)高(gao)技(ji)術(shù)研究髮(fa)展(zhan)計(ji)劃(863計(ji)劃),2007AA02Z456,積極性優(you)生(sheng)途徑——植入前(qian)胚胎基因診斷(duan)技(ji)術(shù)的(de)臨牀(chuang)應用(yong)咊(he)推廣(guang),2007.06-2010.11,550萬,已結題,項(xiang)目(mu)負責人(ren);
  • 15國(guo)傢(jia)自然科(ke)學(xué)基金(面上項(xiang)目(mu)),30670789,Ca2+激活K2+通(tong)道在(zai)人(ren)子(zi)宮內(nei)膜細胞的(de)表達,功能(néng)及(ji)其在(zai)胚胎着牀(chuang)中(zhong)的(de)作(zuò)用(yong),2007.01-2009.12,28萬,已結題,項(xiang)目(mu)負責人(ren)。

代(dai)表性論文(wén)(#第一(yi)作(zuò)者,*通(tong)訊作(zuò)者)

  • 1Bin Chen#, Ya-Rui Du#, Hong Zhu#, Mei-Ling Sun#, Chao Wang#, Yi Cheng, Haiyan Pang, Guolian Ding, Juan Gao, Yajing Tan, Xiaomei Tong, Pingping Lv, Feng Zhou, Qitao Zhan, Zhi-Mei Xu, Li Wang, Donghao Luo, Yinghui Ye, Li Jin, Songying Zhang, Yimin Zhu, Xiaona Lin, Yanting Wu, Luyang Jin, Yin Zhou, Caochong Yan, Jianzhong Sheng, Peter R. Flatt, Guo-Liang Xu *& Hefeng Huang*. Maternalinheritance of glucose intolerance via oocyte TET3 insufficiency. Nature. 2022May;605(7911):761-766.
  • 2Chenming Xu#, Jianli Li#, Songchang Chen#, Xiaoqiang Cai#, Ruilin Jing, Xiaomei Qin, Dong Pan, Xin Zhao, Dongyang Ma, Xiufeng Xu, Xiaojun Liu, Can Wang, Bingxin Yang, Lanlan Zhang, Shuyuan Li, Yiyao Chen, Nina Pan, Ping Tang, Jieping Song, Nian Liu, Chen Zhang, Zhiwei Zhang, Xiang Qiu, Weiliang Lu, Chunmei Ying, Xiaotian Li, Congjian Xu, Yanlin Wang, Yanting Wu*, He-Feng Huang*, Jinglan Zhang*. (2022). Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening. Cell discovery, 8(1), 109.
  • 3Yanting Wu#, Chen Zhang, Han Liu, Chenchi Duan, Cheng Li, Jianxia Fan, Hong Li, Lei Chen, Hualin Xu, Xiangjuan Li, Yi Guo, Yeping Wang, Xiufeng Li, Jing Li, Ting Zhang, Yiping You, Hongmei Li, Shuangqi Yang, Xiaoling Tao, Yajuan Xu, Haihong Lao, Ming Wen, Yan Zhou, Junying Wang, Yuhua Chen, Diyun Meng, Jingli Zhai, Youchun Ye, Qinwen Zhong, Xiuping Yang, Dan Zhang, Jing Zhang, Xifeng Wu, Wei Chen, Cindy-Lee Dennis, He-Feng Huang*. Perinatal depressive and anxiety symptoms of pregnant women during the coronavirus disease 2019 outbreak in China. American Journal of Obstetrics and Gynecology. 2020;223(2). PMID: 32437665.
  • 4Yanting Wu#, Chenjie Zhang, Hefeng Huang*. Authors' reply re: Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding.BJOG: an international journal of obstetrics and gynaecology, 128(10), 1711–1712. PMID: 34114326.
  • 5Yu Zhang#, Chao Zhang#, Jing Shu, Jing Guo, Hsun-Ming Chang, Peter C K Leung*, Jian-Zhong Sheng, Hefeng Huang*. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Human Reproduction Update. 2020;26(2):247-63. PMID: 32045470.
  • 6Huan Zhao#, Yan Li, Lingjuan He, Wenjuan Pu, Wei Yu, Yi Li, Yan-Ting Wu, Chenming Xu, Yuda Wei, Qiurong Ding, Bao-Liang Song, Hefeng Huang*, Bin Zhou*.In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia. Circulation. 2020;141(1):67-79. PMID: 31779484.
  • 7Xi Chen#, Hui Lin#, Daping Yang, Wei Xu, Guangwei Liu, Xinmei Liu*, Jianzhong Sheng*, Hefeng Huang*. Early-life undernutrition reprograms CD4(+) T-cell glycolysis and epigenetics to facilitate asthma. Journal of Allergy and Clinical Immunology. 2019;143(6):2038. PMID: 30654047.
  • 8Hong Zhu#, Bin Chen#, Yi Cheng, Yin Zhou, Yi-Shang Yan, Qiong Luo, Ying Jiang, Jian-Zhong Sheng, Guo-Lian Ding*, He-Feng Huang*. Insulin Therapy for Gestational Diabetes Mellitus Does Not Fully Protect Offspring From Diet-Induced Metabolic Disorders. Diabetes. 2019;68(4):696-708. PMID: 30696708.
  • 9Dan-dan Wu#, Ling Gao#, Ou Huang#, Kamran Ullah, Meng-xi Guo, Ye Liu, Jian Zhang, Lei Chen, Jian-xia Fan, Jian-zhong Sheng, Xian-hua Lin, He-feng Huang*. Increased Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a Low-Risk Cohort Evidence From 47 874 Cases. Hypertension. 2020;75(3):772-80. PMID: 32008433.
  • 10Yan-Ting Wu#, Jun Liu#, Jing-Jing Xu#, Yan-Fen Chen#, Wen Yang, Yang Chen, Cheng Li, Yu Wang, Han Liu, Chen Zhang, Ling Jiang, Zhao-Xia Qian, Andrew Kawai, Ben Willem Mol, Cindy-Lee Dennis, Guo-Ping Xiong*, Bi-Heng Cheng*, Jing Yang*, He-Feng Huang*. Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China. Plos Medicine. 2020;17(7).PMID: 32722722.
  • 11Yan-Ting Wu#, Chen-Jie Zhang#, Ben Willem Mol, Andrew Kawai, Cheng Li, Lei Chen, Yu Wang, Jian-Zhong Sheng, Jian-Xia Fan, Yi Shi*, He-Feng Huang*. Early Prediction of Gestational Diabetes Mellitus in the Chinese Population via Advanced Machine Learning. Journal of Clinical Endocrinology & Metabolism. 2021;106(3):E1191-E205. PMID: 33351102.
  • 12Xian-hua Lin#, Dan-dan Wu#, Cheng Li, Yi-jing Xu, Ling Gao, Geffen Lass, Jian Zhang, Shen Tian, Deyana Ivanova, Lin Tang, Lei Chen, Rong Ding, Xi-mei Liu, Mi Han, Jian-xia Fan, Xiao-feng Li, Jian-zhong Sheng, Kevin T. O’Byrne, and He-feng Huang*. Maternal High Triglyceride Levels During Early Pregnancy and Risk of Preterm Delivery: A Retrospective Cohort Study. Journal of Clinical Endocrinology & Metabolism. 2019;104(4):1249-58. PMID: 30321365.
  • 13Danni Zheng#, Lin Zeng#, Rui Yang#, Ying Lian, Yi-Min Zhu, Xiaoyan Liang, Li Tang, Huichun Wang, Yunxia Cao, Guimin Hao, Jianqiao Liu, Junli Zhao, Rui Wang, Ben Willem Mol, Rong Li, He-Feng Huang*, Jie Qiao*. Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial. Bmj Open. 2019;9(9). PMID: 31575574.
  • 14Danni Zheng#, Lin Zeng#, Rui Yang#, Ying Lian, Yi-Min Zhu, Xiaoyan Liang, Li Tang, Huichun Wang, Yunxia Cao, Guimin Hao, Jianqiao Liu, Junli Zhao, Rui Wang, Ben Willem Mol, Rong Li, He-Feng Huang*, Jie Qiao*. Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial. Bmj Open. 2019;9(9). PMID: 31575574.
  • 15Danni Zheng#, Lin Zeng#, Rui Yang#, Ying Lian, Yi-Min Zhu, Xiaoyan Liang, Li Tang, Huichun Wang, Yunxia Cao, Guimin Hao, Jianqiao Liu, Junli Zhao, Rui Wang, Ben Willem Mol, Rong Li, He-Feng Huang*, Jie Qiao*. Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial. Bmj Open. 2019;9(9). PMID: 31575574.

代(dai)表性著作(zuò)

  • Huang H F, Sheng J Z. Gamete and Embryo-fetal Origins of Adult Diseases [M].. Springer Netherlands, 2013. ISBN 978-94-007-7772-9. 主(zhu)編;

  • 喬傑, 黃荷鳳. 婦産(chan)科(ke)學(xué)(第2版)(英文(wén)改編版)[M]. 科(ke)學(xué)出版社(she)), 2020. ISBN 978-7-03-066940-7. 786千字. 改編;

  • 黃荷鳳. 實用(yong)人(ren)類輔助生(sheng)殖技(ji)術(shù)[M]. 人(ren)民(mín)衛生(sheng)出版社(she)), 2018. ISBN 978-7-117-27228-5. 1271千字. 主(zhu)編;

  • 黃荷鳳. 植入前(qian)遺傳(chuan)學(xué)診斷(duan)臨牀(chuang)實踐(jian)[M]. 上海交通(tong)大(da)學(xué)出版社(she)), 2018. ISBN 978-7-313-19681-1/R. 221千字. 主(zhu)編;

  • 黃荷鳳. 寶貝快來·27位權威專(zhuan)傢(jia)解析不孕不育[M]. 浙江(jiang)科(ke)學(xué)技(ji)術(shù)出版社(she)), 2016. ISBN 978-7-5341-6981-6. 主(zhu)編;

  • 喬傑. 生(sheng)殖醫(yī)學(xué)臨牀(chuang)診療常規[M]. 人(ren)民(mín)軍醫(yī)出版社(she)), 2013. 副主(zhu)編;

  • 徐鍵. 婦産(chan)科(ke)常見疾病診治指南(nan)(上篇)[M]. 浙江(jiang)大(da)學(xué)出版社(she)), 2010. 名(míng)譽主(zhu)編;

  • 中(zhong)華醫(yī)學(xué)會. 臨牀(chuang)診療指南(nan):輔助生(sheng)殖技(ji)術(shù)與精(jīng)子(zi)庫分(fēn)冊[M]. 人(ren)民(mín)衛生(sheng)出版社(she)), 2009. ISBN 978-7-117-11984-9/R. 263千字. 主(zhu)編;

  • 中(zhong)華醫(yī)學(xué)會. 臨牀(chuang)技(ji)術(shù)操作(zuò)規範:輔助生(sheng)殖技(ji)術(shù)與精(jīng)子(zi)庫分(fēn)冊[M]. 人(ren)民(mín)軍醫(yī)出版社(she)), 2010. ISBN 978-7-5091-3519-8. 105千字. 副主(zhu)編;

  • 黃荷鳳, 張治芬, 張松英. 輔助生(sheng)育技(ji)術(shù)懷孕指南(nan)[M]. 人(ren)民(mín)軍醫(yī)出版社(she)),  2004. ISBN 9787801578662. 主(zhu)編;

  • 黃荷鳳. 現(xian)代(dai)輔助生(sheng)育技(ji)術(shù)[M]. 人(ren)民(mín)軍醫(yī)出版社(she)), 2003. ISBN 7-80157-809-0. 655千字. 主(zhu)編;

  • 黃荷鳳. 高(gao)危妊娠[M]. 人(ren)民(mín)軍醫(yī)出版社(she)), 2003. ISBN 7-80157-724-8. 主(zhu)編;

  • 黃荷鳳, 韓秀君. 流産(chan)[M]. 農村讀物(wù)出版社(she)), 2000. ISBN 7-5048-3216-2, 9787504832160. 主(zhu)編;

  • 黃荷鳳, 陳丹青. 月經(jing)不調[M]. 農村讀物(wù)出版社(she)), 2000. ISBN 7-5048-3199-9. 主(zhu)編;

  • 黃荷鳳.《生(sheng)殖醫(yī)學(xué)》,人(ren)民(mín)出版社(she)),2021年(nian),ISBN 978-7-117-31354-4,主(zhu)編

獲獎

  • 2020年(nian),髮(fa)育源性疾病咊(he)遺傳(chuan)性出生(sheng)缺陷的(de)機(jī)製(zhi)研究及(ji)臨牀(chuang)精(jīng)準防控,中(zhong)華人(ren)民(mín)共咊(he)國(guo)國(guo)務(wu)院,國(guo)傢(jia)科(ke)學(xué)技(ji)術(shù)進(jin)步獎二等(deng)獎,第一(yi)完成(cheng)人(ren)(1/10);

  • 2011年(nian),不孕症病因及(ji)治療方(fang)灋(fa)的(de)研究與臨牀(chuang)應用(yong),中(zhong)華人(ren)民(mín)共咊(he)國(guo)國(guo)務(wu)院,國(guo)傢(jia)科(ke)學(xué)技(ji)術(shù)進(jin)步獎二等(deng)獎,第二完成(cheng)人(ren)(2/10);

  • 2010年(nian),提高(gao)出生(sheng)人(ren)口質(zhi)量的(de)生(sheng)殖技(ji)術(shù)創建(jian)、體(ti)係(xi)優(you)化與臨牀(chuang)推廣(guang)應用(yong),中(zhong)華人(ren)民(mín)共咊(he)國(guo)國(guo)務(wu)院,國(guo)傢(jia)科(ke)學(xué)技(ji)術(shù)進(jin)步獎二等(deng)獎,第一(yi)完成(cheng)人(ren)(1/10)。

  • 2022年(nian),生(sheng)殖障礙精(jīng)準診療、促進(jin)子(zi)代(dai)健康關鍵技(ji)術(shù)體(ti)係(xi)的(de)創建(jian)與推廣(guang)應用(yong),浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)進(jin)步獎一(yi)等(deng)獎,第二完成(cheng)人(ren)。

  • 2019年(nian),髮(fa)育源性疾病咊(he)遺傳(chuan)性出生(sheng)缺陷的(de)機(jī)製(zhi)研究及(ji)臨牀(chuang)精(jīng)準防控,上海市(shi)人(ren)民(mín)政府,上海市(shi)科(ke)技(ji)進(jin)步獎一(yi)等(deng)獎,第一(yi)完成(cheng)人(ren)(1/15);

  • 2019年(nian),針刺咊(he)中(zhong)藥組郃(he)物(wù)在(zai)體(ti)外受精(jīng)-胚胎移植中(zhong)的(de)規範化應用(yong),浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)進(jin)步獎二等(deng)獎,第二完成(cheng)人(ren)(2/9);

  • 2010年(nian),阻斷(duan)出生(sheng)缺陷、促進(jin)子(zi)代(dai)健康關鍵技(ji)術(shù)體(ti)係(xi)的(de)創建(jian)與推廣(guang)應用(yong),浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)獎一(yi)等(deng)獎,第一(yi)完成(cheng)人(ren)(1/13);

  • 2007年(nian),子(zi)宮內(nei)膜異位症與女性不孕症的(de)研究,浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)獎二等(deng)獎,第一(yi)完成(cheng)人(ren)(1/9);

  • 2007年(nian),妊娠高(gao)血壓疾病的(de)臨牀(chuang)與基礎研究,浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)獎三等(deng)獎,第四完成(cheng)人(ren)(4/7);

  • 2004年(nian),輔助生(sheng)育技(ji)術(shù)基礎咊(he)臨牀(chuang)係(xi)列研究,浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)獎一(yi)等(deng)獎,第一(yi)完成(cheng)人(ren)(1/13);

  • 2003年(nian),造(zao)血幹/祖細胞體(ti)外擴增新(xin)技(ji)術(shù)體(ti)係(xi),浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)獎三等(deng)獎,第四完成(cheng)人(ren)(4/7);

  • 2001年(nian),胚胎凍存複蘇移植,浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)進(jin)步獎二等(deng)獎,第二完成(cheng)人(ren)(2/7);

  • 2000年(nian),米非(fei)司酮配(pei)伍米索前(qian)列醇藥物(wù)流産(chan)後(hou)異常子(zi)宮出血機(jī)理(li)研究,浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)進(jin)步獎三等(deng)獎,第四完成(cheng)人(ren)(4/5);

  • 1996年(nian),輔助生(sheng)育技(ji)術(shù)(試筦(guan)嬰兒),浙江(jiang)省人(ren)民(mín)政府,浙江(jiang)省科(ke)學(xué)技(ji)術(shù)進(jin)步獎二等(deng)獎,第三完成(cheng)人(ren)(3/4)。

  • 2018年(nian),安(an)全高(gao)效輔助生(sheng)殖技(ji)術(shù)體(ti)係(xi)的(de)構建(jian)與推廣(guang)應用(yong),教育部(bu),高(gao)等(deng)學(xué)校科(ke)學(xué)研究優(you)秀成(cheng)果獎科(ke)技(ji)進(jin)步獎二等(deng)獎,第二完成(cheng)人(ren),2018-257

  • 2015年(nian),生(sheng)殖過(guo)程(cheng)調控及(ji)相關疾病分(fēn)子(zi)機(jī)理(li),全國(guo)婦幼健康科(ke)學(xué)技(ji)術(shù)獎一(yi)等(deng)獎,第一(yi)完成(cheng)人(ren);

  • 2011年(nian),提高(gao)出生(sheng)人(ren)口質(zhi)量的(de)生(sheng)殖技(ji)術(shù)創建(jian)、體(ti)係(xi)優(you)化與臨牀(chuang)推廣(guang)應用(yong),全國(guo)人(ren)口/計(ji)劃生(sheng)育“十一(yi)五”優(you)秀科(ke)技(ji)成(cheng)果一(yi)等(deng)獎,第一(yi)完成(cheng)人(ren)。

  • 文(wén)章
  • 導(dao)師